Clinical characteristics of CLL samples
| Parameters . | All patients . | UM, ≥ 98% . | MT, < 98% . |
|---|---|---|---|
| No. of patients (%) | 107 (100) | 52 (49) | 55 (51) |
| Sex, no. (%) | |||
| Male | 64 (60) | 34 | 30 |
| Female | 43 (40) | 18 | 25 |
| Age at diagnosis, y | |||
| Median | 57.0 | 58.0 | 56.0 |
| Range | 33.0-83.0 | 33.0-83.0 | 41.0-82.0 |
| Rai stage, no. (%) | |||
| 0 | 45 (42) | 10 | 35 |
| I | 29 (27) | 17 | 12 |
| II | 19 (18) | 14 | 5 |
| III-IV | 14 (13) | 11 | 3 |
| Time to treatment | |||
| Median time to first treatment, y | 6.4 | 3.5 | 13.5 |
| No. treated (%) | 56 (52) | 37 | 19 |
| No. censored events (%) | 51 (48) | 15 | 36 |
| Parameters . | All patients . | UM, ≥ 98% . | MT, < 98% . |
|---|---|---|---|
| No. of patients (%) | 107 (100) | 52 (49) | 55 (51) |
| Sex, no. (%) | |||
| Male | 64 (60) | 34 | 30 |
| Female | 43 (40) | 18 | 25 |
| Age at diagnosis, y | |||
| Median | 57.0 | 58.0 | 56.0 |
| Range | 33.0-83.0 | 33.0-83.0 | 41.0-82.0 |
| Rai stage, no. (%) | |||
| 0 | 45 (42) | 10 | 35 |
| I | 29 (27) | 17 | 12 |
| II | 19 (18) | 14 | 5 |
| III-IV | 14 (13) | 11 | 3 |
| Time to treatment | |||
| Median time to first treatment, y | 6.4 | 3.5 | 13.5 |
| No. treated (%) | 56 (52) | 37 | 19 |
| No. censored events (%) | 51 (48) | 15 | 36 |